Ji H. Park

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

A Delphi Survey on the Validity and Feasibility of a Healthcare-Associated Infection Surveillance System for Traditional Korean Medicine Hospitals in South Korea.

A Delphi Survey on the Validity and Feasibility of a Healthcare-Associated Infection Surveillance System for Traditional Korean Medicine Hospitals in South Korea.

Journal: Healthcare (Basel, Switzerland)

Published: February 05, 2025

Recent advances in photoelectrochemical hydrogen production using I-III-VI quantum dots.

Recent advances in photoelectrochemical hydrogen production using I-III-VI quantum dots.

Journal: Nanoscale

Published: April 29, 2024

Synergistic Effect of HAD-B1 and Afatinib Against Gefitinib Resistance of Non-Small Cell Lung Cancer.

Synergistic Effect of HAD-B1 and Afatinib Against Gefitinib Resistance of Non-Small Cell Lung Cancer.

Journal: Integrative cancer therapies

Published: December 24, 2022

Selective Immune Modulating Activities of Viscum album and Its Components; A Possibility of Therapeutics on Skin Rash Induced by EGFR Inhibitors.

Selective Immune Modulating Activities of Viscum album and Its Components; A Possibility of Therapeutics on Skin Rash Induced by EGFR Inhibitors.

Journal: Integrative cancer therapies

Published: September 26, 2022

The Current Status of Integrative Oncology in Korea.

The Current Status of Integrative Oncology in Korea.

Journal: Integrative cancer therapies

Published: December 07, 2021

Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Exploratory Study to Evaluate the Efficacy and Safety of HAD-B1 for Dose-Finding in EGFR Mutation Positive and Locally Advanced or Metastatic NSCLC Subjects Who Need Afatinib Therapy.

Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Exploratory Study to Evaluate the Efficacy and Safety of HAD-B1 for Dose-Finding in EGFR Mutation Positive and Locally Advanced or Metastatic NSCLC Subjects Who Need Afatinib Therapy.

Journal: Integrative cancer therapies

Published: August 19, 2021

Acute and Subchronic Toxicological Evaluation of the Herbal Product HAD-B1 in Rats.

Acute and Subchronic Toxicological Evaluation of the Herbal Product HAD-B1 in Rats.

Journal: Evidence-based complementary and alternative medicine : eCAM

Published: March 31, 2021

The Survival Benefit of Combination Therapy With Mild Temperature Hyperthermia and an Herbal Prescription of Gun-Chil-Jung in 54 Cancer Patients Treated With Chemotherapy or Radiation Therapy: A Retrospective Study.

The Survival Benefit of Combination Therapy With Mild Temperature Hyperthermia and an Herbal Prescription of Gun-Chil-Jung in 54 Cancer Patients Treated With Chemotherapy or Radiation Therapy: A Retrospective Study.

Journal: Integrative cancer therapies

Published: May 26, 2020

Histologic purity of signet ring cell carcinoma is a favorable risk factor for lymph node metastasis in poorly cohesive, submucosa-invasive early gastric carcinoma.

Histologic purity of signet ring cell carcinoma is a favorable risk factor for lymph node metastasis in poorly cohesive, submucosa-invasive early gastric carcinoma.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: July 01, 2016

Tristetraprolin suppresses the EMT through the down-regulation of Twist1 and Snail1 in cancer cells.

Tristetraprolin suppresses the EMT through the down-regulation of Twist1 and Snail1 in cancer cells.

Journal: Oncotarget

Published: August 20, 2015

Incidence and malignancy rates of diagnoses in the bethesda system for reporting thyroid aspiration cytology: an institutional experience.

Incidence and malignancy rates of diagnoses in the bethesda system for reporting thyroid aspiration cytology: an institutional experience.

Journal: Korean journal of pathology

Published: February 17, 2014

Spontaneous regression of non-small cell lung cancer in a patient with idiopathic pulmonary fibrosis: a case report.

Spontaneous regression of non-small cell lung cancer in a patient with idiopathic pulmonary fibrosis: a case report.

Journal: Tuberculosis and respiratory diseases

Published: May 28, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026